A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

August 31, 2006

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

AG-013,958

Trial Locations (39)

Unknown

Pfizer Investigational Site, Mesa

Pfizer Investigational Site, Oro Valley

Pfizer Investigational Site, Phoenix

Pfizer Investigational Site, Sun City

Pfizer Investigational Site, Tucson

Pfizer Investigational Site, Tuscon

Pfizer Investigational Site, Beverly Hills

Pfizer Investigational Site, Fort Myers

Pfizer Investigational Site, Tampa

Pfizer Investigational Site, Iowa City

Pfizer Investigational Site, Chevy Chase

Pfizer Investigational Site, Hagerstown

Pfizer Investigational Site, Boston

Pfizer Investigational Site, Ann Arbor

Pfizer Investigational Site, Livonia

Pfizer Investigational Site, Rochester

Pfizer Investigational Site, Royal Oak

Pfizer Investigational Site, Saint Clair Shores

Pfizer Investigational Site, Ypsilanti

Pfizer Investigational Site, Slingerlands

Pfizer Investigational Site, Charlotte

Pfizer Investigational Site, Huntersville

Pfizer Investigational Site, Cleveland

Pfizer Investigational Site, Lakewood

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Chambersburg

Pfizer Investigational Site, Columbia

Pfizer Investigational Site, Knoxville

Pfizer Investigational Site, Houston

Pfizer Investigational Site, Fairfax

Pfizer Investigational Site, Sydney

Pfizer Investigational Site, East Melbourne

Pfizer Investigational Site, Nijmegen

Pfizer Investigational Site, Amsterdam

Pfizer Investigational Site, Groningen

Pfizer Investigational Site, Rotterdam

Pfizer Investigational Site, Aberdeen

Pfizer Investigational Site, Bristol

Pfizer Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY